Min Osteopat ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  5.6% 5.7% 10.9% 21.0% 16.2%  
Credit score (0-100)  42 41 22 4 10  
Credit rating  BBB BBB BB B BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12

Net sales  1,255 660 7   0  
Gross profit  954 295 -1.6 -12.1 -12.5  
EBITDA  954 295 -1.6 -12.1 -12.5  
EBIT  949 258 -38.8 -49.3 -49.7  
Pre-tax profit (PTP)  942.6 255.7 -42.8 -50.3 -50.4  
Net earnings  731.9 198.9 -35.1 -37.6 -39.3  
Pre-tax profit without non-rec. items  943 256 -42.8 -50.3 -50.4  

 
See the entire income statement

Balance sheet (kDKK) 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12

Tangible assets total  181 144 106 69.2 31.9  
Shareholders equity total  782 250 215 177 138  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,174 327 232 177 138  

Net Debt  -566 -181 -126 -96.1 -82.9  
 
See the entire balance sheet

Volume 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12

Net sales  1,255 660 7 0 0  
Net sales growth  0.0% -47.4% -98.9% -93.6% -100.0%  
Gross profit  954 295 -1.6 -12.1 -12.5  
Gross profit growth  0.0% -69.1% 0.0% -658.8% -3.7%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,174 327 232 177 138  
Balance sheet change%  0.0% -72.2% -28.9% -23.7% -22.2%  
Added value  954.4 295.0 -1.6 -12.1 -12.5  
Added value %  76.1% 44.7% -22.7% -2,677.8% 0.0%  
Investments  176 -74 -74 -74 -74  

Net sales trend  0.0 -1.0 -2.0 -3.0 -4.0  
EBIT trend  1.0 2.0 -1.0 -2.0 -3.0  

Profitability 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
EBITDA %  76.1% 44.7% -22.7% -2,677.8% 0.0%  
EBIT %  75.6% 39.0% -554.6% -10,951.6% 0.0%  
EBIT to gross profit (%)  99.4% 87.4% 2,444.6% 409.0% 397.9%  
Net Earnings %  58.3% 30.1% -500.9% -8,345.3% 0.0%  
Profit before depreciation and extraordinary items %  58.7% 35.8% 31.0% -71.6% 0.0%  
Pre tax profit less extraordinaries %  75.1% 38.7% -611.1% -11,183.6% 0.0%  
ROA %  80.9% 34.4% -13.9% -24.1% -31.6%  
ROI %  120.0% 49.1% -16.4% -25.1% -31.6%  
ROE %  93.6% 38.6% -15.1% -19.2% -25.0%  

Solidity 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Equity ratio %  66.6% 76.5% 92.4% 100.0% 100.0%  
Relative indebtedness %  30.5% 10.4% 239.0% 0.0% 0.0%  
Relative net indebtedness %  -14.6% -17.0% -1,559.9% -21,354.4% 0.0%  
Net int. bear. debt to EBITDA, %  -59.3% -61.2% 7,929.6% 797.5% 663.1%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Quick Ratio  5.7 16.5 7.5 0.0 0.0  
Current Ratio  5.7 16.5 7.5 0.0 0.0  
Cash and cash equivalent  565.7 180.7 125.9 96.1 82.9  

Capital use efficiency 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Trade debtors turnover (days)  7.8 1.3 0.0 0.0 0.0  
Trade creditors turnover (days)  163.4 0.0 531.3 0.0 0.0  
Current assets / Net sales %  79.1% 27.7% 1,798.9% 21,354.4% 0.0%  
Net working capital  817.4 172.0 109.2 96.1 82.9  
Net working capital %  65.1% 26.0% 1,559.9% 21,354.4% 0.0%  

Employee efficiency 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0